Johnson & Johnson to purchase heart pump maker Abiomed for $16.6bn

Raghuram Kadari- November 2, 2022 0

Johnson & Johnson (J&J) has agreed to acquire Abiomed, a NASDAQ-listed cardiovascular medical technology provider, in an all-cash deal valued at approximately $16.6 billion. The ... Read More

Novo Nordisk to acquire cardio-renal disease company Corvidia Therapeutics

pharmanewsdaily- June 14, 2020 0

Novo Nordisk acquisition of Corvidia : Danish pharma company Novo Nordisk has agreed to acquire Corvidia Therapeutics from life sciences venture capital firm Sofinnova Partners ... Read More

Lilly bags Trulicity FDA approval for reducing CV risk in type 2 diabetes patients

pharmanewsdaily- February 22, 2020 0

Trulicity FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug Administration (FDA) for Trulicity (dulaglutide) to reduce ... Read More

Amarin bags Vascepa FDA approval for reducing cardiovascular risk

pharmanewsdaily- December 16, 2019 0

Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA) for a new indication and label expansion ... Read More

Novartis to acquire The Medicines Company for $9.7bn with eye on inclisiran

pharmanewsdaily- November 25, 2019 0

Novartis acquisition of The Medicines Company : Swiss drugmaker Novartis signed a deal worth $9.7 billion to acquire US biopharma company The Medicines Company, as ... Read More

Regeneron and Sanofi’s Praluent gets European approval for reducing cardiovascular risk in atherosclerotic disease patients

pharmanewsdaily- March 24, 2019 0

Regeneron Pharmaceuticals and Sanofi have received a significant boost with the European Commission's (EC) approval of Praluent (alirocumab) for a new indication. The approval enables ... Read More

An egg a day might reduce risk of heart disease: Study

pharmanewsdaily- January 28, 2019 0

New Delhi, Jan 28 (ANI): A new study conducted in China finds that eating an egg a day may lower risk of cardiovascular disease. The ... Read More

FDA approves Novo Nordisk’s Victoza for heart disease treatment in type 2 diabetes patients

pharmanewsdaily- August 26, 2017 0

In a significant advancement for diabetes care, Danish pharmaceutical giant Novo Nordisk has received approval from the U.S. Food and Drug Administration (FDA) to use ... Read More

What meant is by Tachycardia?

pharmanewsdaily- September 17, 2013 0

Tachycardia: Tachycardia is a medical term for the conditions like rapid heart beat, fluttering heart or pounding of heart. Causes for Tachycardia: Sinus tachycardia (Photo ... Read More